| Insider Name | Buy/Sell | Amount | Shares Change | |||
|---|---|---|---|---|---|---|
| Jul 19, 2021 | Jul 21, 2021 | Willwerth Christina Chief Strategy Officer | Sell | $6.45 | $25,445 | -2.72% |
| Jul 19, 2021 | Jul 21, 2021 | Wentworth Kerry Chief Regulatory Officer | Sell | $6.45 | $25,439 | -2.62% |
| Jul 19, 2021 | Jul 21, 2021 | Muzikant Adam Chief Business Officer | Sell | $6.45 | $12,062 | -1.77% |
| Jul 19, 2021 | Jul 21, 2021 | Levine Mark S. GC | Sell | $6.45 | $25,445 | -2.87% |
| May 10, 2021 | May 12, 2021 | Arkowitz David CFO | Sell | $7.23 | $16,116 | -1.00% |
| Mar 15, 2021 | Mar 16, 2021 | Layman Melissa Chief Commercial Officer | Sell | $11.8 | $53,336 | -4.17% |
| Jan 28, 2021 | Jan 30, 2021 | Layman Melissa Chief Commercial Officer | Sell | $12.55 | $32,931 | -2.88% |
| Jan 05, 2021 | Jan 07, 2021 | Muzikant Adam Chief Business Officer | Sell | $11.13 | $44,576 | -5.17% |
| Jan 05, 2021 | Jan 07, 2021 | Kelley Scott Chief Medical Officer | Sell | $11.13 | $76,007 | -5.67% |
| Jan 05, 2021 | Jan 07, 2021 | Wentworth Kerry Chief Regulatory Officer | Sell | $11.13 | $76,007 | -5.39% |
| Jan 05, 2021 | Jan 07, 2021 | Willwerth Christina Chief Strategy Officer | Sell | $11.13 | $73,480 | -5.42% |
| Jan 05, 2021 | Jan 07, 2021 | Levine Mark S. GC | Sell | $11.13 | $76,007 | -5.98% |
| Jan 05, 2021 | Jan 07, 2021 | Arkowitz David CFO | Sell | $11.13 | $67,592 | -3.87% |
| May 26, 2020 | May 27, 2020 | Stejbach Mark Dir | Buy | $9.75 | $19,997 | +36.10% |
| May 26, 2020 | May 27, 2020 | Clayman Michael D. Pres CEO | Buy | $9.75 | $99,996 | +1.23% |
| May 07, 2020 | May 11, 2020 | Arkowitz David CFO | Sell | $10.88 | $26,253 | -2.02% |
| Jan 03, 2020 | Jan 07, 2020 | Willwerth Christina Chief Strategy Officer | Sell | ~ | $0 | -6.31% |
| Jan 03, 2020 | Jan 07, 2020 | Kelley Scott Chief Medical Officer | Sell | ~ | $0 | -7.01% |
| Jan 03, 2020 | Jan 07, 2020 | Levine Mark S. GC | Sell | ~ | $0 | -7.89% |
| Jan 03, 2020 | Jan 07, 2020 | Wentworth Kerry Chief Regulatory Officer | Sell | ~ | $0 | -6.23% |
| Jan 03, 2020 | Jan 07, 2020 | Arkowitz David CFO | Sell | ~ | $0 | -3.38% |
| Jan 03, 2020 | Jan 07, 2020 | Bodick Neil Chief Scientific Officer | Sell | ~ | $0 | -0.78% |
| Aug 08, 2019 | Aug 09, 2019 | Colella Samuel D Dir 10% | Buy | $10.74 | $21,480 | +0.05% |
| Aug 08, 2019 | Aug 08, 2019 | Clayman Michael D. Pres CEO | Buy | $10.85 | $25,136 | +0.29% |
| May 31, 2019 | Jun 03, 2019 | Arkowitz David CFO | Buy | $11.05 | $27,627 | +2.72% |
| May 23, 2019 | May 24, 2019 | Merrifield C Ann Dir | Buy | $12.64 | $101,120 | +44.44% |
| May 13, 2019 | May 15, 2019 | Arkowitz David CFO | Buy | $11.99 | $47,960 | +4.40% |
| May 10, 2019 | May 13, 2019 | Clayman Michael D. Pres CEO | Buy | $12.48 | $50,067 | +0.50% |
| May 08, 2019 | May 09, 2019 | Arkowitz David CFO | Sell | $10.06 | $22,615 | -2.64% |
| Mar 12, 2019 | Mar 13, 2019 | Clayman Michael D. Pres CEO | Buy | $12.36 | $50,009 | +0.50% |
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.